The surgical management of sporadic primary hyperparathyroidism

Best Pract Res Clin Endocrinol Metab. 2018 Dec;32(6):847-859. doi: 10.1016/j.beem.2018.12.001. Epub 2018 Dec 6.

Abstract

Sporadic primary hyperparathyroidism (pHPT) is the commonest cause of hypercalcaemia in the ambulatory population. It has a female preponderance and its incidence is increasing. In 85% of cases it is caused by a single parathyroid adenoma, with four gland hyperplasia in up to 20%. Parathyroidectomy is the only cure and bilateral neck exploration remains the gold standard to achieve this. Several adjuncts have been developed to improve success rates or limit the extent of surgery. Pre-operative localisation permits planned targeted surgery. Ultrasound scanning and scintigraphy are the most commonly employed, although 4DCT has become a useful modality in complex cases. However, excellent rates of biochemical cure can be achieved in specialist centres when pre-operative imaging is negative. Pre-operative prediction models and intra-operative parathyroid hormone (ioPTH) assist, with high sensitivity, to predict single gland disease. Reoperations present a major challenge to the endocrine surgeon.

Keywords: intra-operative PTH; parathyroid imaging; parathyroidectomy; primary hyperparathyroidism.

Publication types

  • Review

MeSH terms

  • Adenoma / complications
  • Adenoma / diagnosis
  • Adenoma / epidemiology
  • Adenoma / surgery
  • Female
  • Humans
  • Hypercalcemia / complications
  • Hypercalcemia / diagnosis
  • Hypercalcemia / epidemiology
  • Hypercalcemia / surgery
  • Hyperparathyroidism, Primary / diagnosis
  • Hyperparathyroidism, Primary / epidemiology
  • Hyperparathyroidism, Primary / surgery*
  • Male
  • Parathyroid Hormone / blood
  • Parathyroid Neoplasms / complications
  • Parathyroid Neoplasms / diagnosis
  • Parathyroid Neoplasms / epidemiology
  • Parathyroid Neoplasms / surgery
  • Parathyroidectomy / methods*
  • Radionuclide Imaging
  • Ultrasonography

Substances

  • Parathyroid Hormone